Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Guilin Sanjin Pharmaceutical Co Ltd

+ Add to Watchlist

002275:CH

19.010 CNY 0.230 1.20%

As of 02:00:30 ET on 01/30/2015.

Snapshot for Guilin Sanjin Pharmaceutical Co Ltd (002275)

Open: 19.330 Day's Range: 18.830 - 19.330 Volume: 3,420,548
Previous Close: 19.240 52wk Range: 14.300 - 20.970 1-Yr Rtn: +35.91%

Stock Chart for 002275

No chart data available.
  • 002275:CH 19.010
  • 1D
  • 1M
  • 1Y
19.240
Interactive 002275 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002275

Current P/E Ratio (ttm) 25.7205
Estimated P/E(12/2014) 24.1550
Relative P/E vs. SZASHR 0.6612
Earnings Per Share (CNY) (ttm) 0.7391
Est. EPS (CNY) (12/2014) 0.7870
Est. PEG Ratio -
Market Cap (M CNY) 11,219.70
Shares Outstanding (M) 590.20
30 Day Average Volume 2,664,725
Price/Book (mrq) 5.0886
Price/Sale (ttm) 7.7756
Dividend Indicated Gross Yield 2.89%
Cash Dividend (CNY) 0.5500
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 04/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002275

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002275

Guilin Sanjin Pharmaceutical Co Ltd is a pharmaceutical company. The Company specializes in research and production of Traditional Chinese Medicine(TCM) and natural medicines.

Wang XufeiVice Chairman/PresidentZou XunVice Chairman/Exec VP/Secr
Xie YuangangVP/Principal:FinanceZou ZhunVice President
More Company Profile & Key Executives for 002275

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil